Article
Vienna, Austria—Until recently, there was little, if any, communication among regional and national glaucoma societies that might reveal greater insights or solutions for the management and treatment of the disease.
Iantrek, Inc. announces 1-Year outcomes from the CREST Registry for bio-interventional glaucoma treatment
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Study: Elevated NLR and SII levels linked to higher risk of cystoid macular edema
Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD
4-Year research validates DOT 0.2 spectacle lenses as early myopia treatment
Enhancing precision in GA imaging